Neoantigens
Neoantigens: are antigens encoded by tumor-specific mutated genes. Studies in the past few years have suggested a key role for neoantigens in cancer immunotherapy.
What's Popular in Neoantigens
JUN 03, 2020
3:00 PM PDT
C.E. CREDITS
JUN 03, 2020
3:00 PM PDT
Neoantigen based personalized immuno-oncology drugs are a relatively new therapeutic avenue that have shown strong anti-tumor efficacy in the clinic. Neoantigen peptides have been widely rep...
C.E. CREDITS
NCI estimates that cancer will be the leading cause of death in 2030, worldwide. Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durabl...
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
